Multicentre study on coaching and point-of-care technologies for patients with myalgic encephalomyelitis/chronic fatigue syndrome

Multicentre study of the effectiveness of multimodal coaching interventions and the feasibility of point-of-care test device for improving the quality of life, functional capacity, and self-management in patients with myalgic encephalomyelitis/chronic fatigue syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN16025168

Enrollment

210

Registered

2026-03-27

Start date

2026-09-01

Completion date

Unknown

Last updated

2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Improving the quality of life of patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Nervous System Diseases

Interventions

Study Methodology and Interventions This is a multicentre, mixed-design interventional study consisting of three study arms evaluating multimodal coaching interventions and the feasibility of a point-

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-75 years 2. Diagnosis of ME/CFS according to International Consensus Criteria (ICC), or Canadian Consensus Criteria (CCC), or Institute of Medicine/National Academy of Medicine (IOM/NAM) criteria, or National Institute for Health and Care Excellence (NICE) criteria 3. Mild, moderate or severe functional impairment (e.g., = 4 Bell Disability Scale = 70) 4. Capacity to provide Informed Consent

Exclusion criteria

Exclusion criteria: 1. Primary psychiatric disorders (e.g., schizophrenia, bipolar disorder) 2. Severe comorbidities that interfere with participation 3. Current participation in another interventional trial

Countries

Canada, France, Italy, Latvia

Contacts

Public ContactModra Murovska

Modra.Murovska@rsu.lv+371 29218082

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 23, 2026